Chicago-based Endotronix has added another $12 million in funding to further development on its wireless, remote cardiac monitor system. The money comes in the form a loan agreement with Silicon ...

Cardiac Arrhythmias Monitoring Devices Market By Type (Implantable, Wearable, External), By Application (Hospitals, Clinics, Home Care Settings, Others), By Region Forecast to 2032 New York, United ...

BEND, Ore.--(BUSINESS WIRE)--Vector Remote Care, an industry pioneer in remote cardiac device monitoring with more than 250 years of collective cardiac expertise, today announced the launch of Vector ...

BOSTON--(BUSINESS WIRE)--InfoBionic.Ai, an innovative digital health company providing industry-validated highest quality ECG and AI-powered diagnostic remote patient monitoring solutions, announces ...

Remote biometric monitoring technology company Biotricity recently announced securing National Institutes of Health funding from the National Heart, Blood and Lung Institute with plans to launch a ...

New York, USA, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Global Cardiac Monitoring Devices Market to Cross USD 30 Billion by 2032, Driven by Telehealth and Remote Monitoring Trends | DelveInsight The global ...

The MarketWatch News Department was not involved in the creation of this content. New single-lead patch strengthens the company's advanced ECG monitoring platform. BOSTON, Aug. 5, 2025 ...

FDA Approves New ICDs and CRT-Ds with Advanced Remote Capabilities DUBLIN, May 08, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced results from late-breaking clinical trials ...

Please provide your email address to receive an email when new articles are posted on . Modeling data of more than 32,000 patients suggest remote vs. conventional monitoring of cardiac implantable ...

REDWOOD CITY, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the launch of its Bioflux® ...

DUBLIN, Sept. 23, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced first enrollments in the ALLEVIATE-HF clinical trial which will evaluate the ...